The first baby has been born after a uterus transplant from a dead donor
A woman who received a uterus transplant from a deceased donor has given birth to a healthy baby girl, according to a paper in the Lancet.
The news: The 32-year-old mother suffers from Mayer-Rokitansky-Küster-Hauser syndrome and was born without a uterus. But in September 2016, surgeons at the University of São Paulo in Brazil conducted a 10-hour transplant operation to provide her with one taken from a dead donor. Seven months later, the team transferred an IVF-created embryo into the womb. The baby was delivered by caesarean section in December 2017. The donor, who was 45 when she died of a brain hemorrhage, had delivered three children.
World first: Until this point, only uterus transplants from living donors had led to successful births. The 10 previous attempts to achieve pregnancies using uteruses from dead donors failed or led to miscarriages. Uterus transplantation, even from living donors, is still a very new procedure. The first successful birth from a living uterus donor was in Sweden in 2014, and there have only been 11 babies delivered that way since.
Why this matters: Expanding the pool of donors to include the dead as well as the living could help increase the number of available uteruses. Few people are willing to give up their wombs while they’re alive, but it might prove easier to convince people to bequeath them, especially those already signed up for organ donations.
Deep Dive
Biotechnology and health
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
An AI-driven “factory of drugs” claims to have hit a big milestone
Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology
The quest to legitimize longevity medicine
Longevity clinics offer a mix of services that largely cater to the wealthy. Now there’s a push to establish their work as a credible medical field.
There is a new most expensive drug in the world. Price tag: $4.25 million
But will the latest gene therapy suffer the curse of the costliest drug?
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.